The role of PTEN in allergic inflammation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 4, 2004, Pages 250-254

  Lee, Yong Chul ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Bronchial asthma; Eosinophilia; Inflammation; Phosphatidylinositol 3 kinase; PTEN; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COMPLEMENTARY DNA; INTERLEUKIN 4; INTERLEUKIN 5; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TENSIN; UNCLASSIFIED DRUG; WORTMANNIN;

ADENOVIRUS; ALLERGENICITY; ALLERGY; ASTHMA; CELL HYPERPLASIA; CHRONIC INFLAMMATION; EOSINOPHILIA; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MUCUS SECRETION; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; RESPIRATORY TRACT DISEASE; REVIEW; STIMULUS RESPONSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ASTHMA; HUMANS; INFLAMMATION; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 4944247366     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Cantley L. C. and Neel B.G. (1999): New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA, 96, 4240-4245.
2. Di Cristofano A., Pesce B., Cordon-Cardo C. and Pandolfi P. P. (1998): PTEN is essential for embryonic development and tumour suppression. Nat. Genet., 19, 348-355.
3. Dunzendorfer S., Meierhofer C. and Wiedermann C. J. (1998): Signaling in neuropeptide-induced migration of human eosinophils. J. Leukoc. Biol., 64, 828-834.
4. Ezeamuzie C. I., Sukumaran J. and Philips E. (2001): Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in Guinea pigs in vivo. Am. J. Respir. Crit. Care. Med., 164, 1633-1639.
5. Frigas E. and Gleich G. J. (1986): The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol., 77, 527-537.
6. Gleich G. J. (2000): Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol., 105, 651-663.
7. Kwak Y. G., Song C. H., Yi H. K., Hwang P. H., Kim J. S., Lee K. S. and Lee Y. C. (2003): Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest., 111, 1083-1092.
8. Lee J. O., Yang H., Georgescu M. M., Di Cristofano A., Maehama T., Shi Y., Dixon J. E., Pandolfi P. and Pavletich N. P. (1999): Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99, 323-334.
9. Leslie N. R. and Downes C. P. (2002): PTEN: the down side of PI 3-kinase signalling. Cell Signal., 14, 285-295.
10. Lu Y., Lin Y. Z., LaPushin R., Cuevas B., Fang X., Yu S. X., Davies M. A., Khan H., Furui T., Mao M., Zinner R., Hung M. C., Steck P., Siminovitch K. and Mills G. B. (1999): The TEN/MMAC1/ /TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene, 18, 7034-7045.
11. Maehama T. and Dixon J. E. (1998): The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273, 13375-13378.
12. Myers M. P., Pass I., Batty I. H., Van der Kaay J., Stolarov J. P., Hemmings B. A., Wigler M. H., Downes C. P. and Tonks N. K. (1998): The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA, 95, 13513-13518.
13. Palframan R. T., Collins P. D., Severs N. J., Rothery S., Williams T. J. and Rankin S.M. (1998): Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J. Exp. Med., 188, 1621-1632.
14. Sun H., Lesche R., Li D. M., Liliental J., Zhang H., Gao J., Gavrilova N., Mueller B., Liu X. and Wu H. (1999): PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA, 96, 6199-6204.
15. Tigani B., Hannon J. P., Mazzoni L. and Fozard J. R. (2001): Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats. Eur. J. Pharmacol., 433, 217-223.
16. Waite K. A. and Eng C. (2002): Protean PTEN: form and function. Am. J. Hum. Genet., 70, 829-844.
17. WHO/NHLBI (2002): Workshop Report. National Institutes of Health, National Heart, Lung, and Blood Institute.
18. Yamada K. M. and Araki M. (2001): Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci., 114, 2375-2382.
19. Zhu X., Subbaraman R., Sano H., Jacobs B., Sano A., Boetticher E., Munoz N. M. and Leff A. R. (2000): A surrogate method for assessment of β(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. J. Immunol. Methods, 240, 157-164.